Loading...
Docoh
Log in Free sign up

Cardinal Health (CAH)

Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With 50 years in business, operations in 46 countries and approximately 48,000 employees globally, Cardinal Health is essential to care.

Company profile

Ticker
CAH
Exchange
NYSE
Website
www.cardinalhealth.com
CEO
Michael Kaufmann
Employees
Incorporated
Ohio
Location
Ohio
Fiscal year end
Jun 30
Sector
Wholesale Trade > Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
Industry (SIC)
Wholesale - Drugs, Proprietaries & Druggists' Sundries
Mckesson • Amerisource Bergen • Herbalife Nutrition • Nu Skin Enterprises • PetIQ • BIMI International Medical • Merion • Trxade Health • DH Enchantment • Can B ...
Former names
CARDINAL DISTRIBUTION INC
SEC CIK
0000721371
Corporate docs
Subsidiaries
A+ Secure Packaging, LLC • Access Closure, Inc. • Aero-Med, Ltd. • Allegiance Corporation • AssuraMed, Inc. • Cardinal Health 2, LLC • Cardinal Health 3, LLC • Cardinal Health 5, LLC • Cardinal Health 6, Inc. • Cardinal Health 7, LLC ...
IRS number
310958666

CAH stock data

News

From Benzinga Pro
Recession Investing: 5 High Yield Dividend Stocks For A Downturn
3 Aug 22
As the healthcare industry absorbed enormous amounts of profits during the Covid-19 pandemic, many healthcare companies will be increasing shareholder distributions to entice investors to buy their stock.
McDonald's Bolsters Digital Vision With New Senior Appointment
1 Aug 22
Quipt Home Medical Announces Supply Contract With Cardinal Health Further Expanding Continuum of Care
25 Jul 22
Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT, TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, is very
What 4 Analyst Ratings Have To Say About Cardinal Health
14 Jul 22
Morgan Stanley Maintains Overweight on Cardinal Health, Lowers Price Target to $70
14 Jul 22

Press releases

From Benzinga Pro
Cardinal Health Names Michelle Greene as Chief Information Officer
1 Aug 22
Greene previously served as SVP of EIT for the company's Pharmaceutical Segment DUBLIN, Ohio, Aug. 1, 2022 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that Michelle Greene has been named chief
RxLive Raises $5 Million Series A to Deliver Population Health Telepharmacy Solutions for At-Risk Patients
26 Jul 22
ST. PETERSBURG, Fla., July 26, 2022 (GLOBE NEWSWIRE) -- RxLive, a provider of population health pharmacy solutions, today announced a $5 million Series A funding round. The digital health startup's round was led by
Quipt Home Medical Announces Supply Contract with Cardinal Health Further Expanding Continuum of Care
25 Jul 22
CINCINNATI, July 25, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory
Summary Notice to Stockholders of Cardinal Health, Inc. of Proposed Settlement of Stockholder Derivative Action, Settlement Hearing, and Right to Appear
22 Jul 22
Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2022 on August 11
7 Jul 22

Analyst ratings and price targets

Last 3 months
Current price
Average target
$67.33
Low target
$64.00
High target
$70.00
Morgan Stanley
Maintains
Overweight
$70.00
14 Jul 22
Barclays
Downgraded
Equal-Weight
$64.00
26 May 22
Evercore ISI Group
Upgraded
Outperform
$68.00
18 May 22

Calendar

4 May 22
9 Aug 22
30 Jun 23

Financial summary

Financial statements Chart CAH financial data
Quarter (USD) Mar 22 Dec 21 Sep 21 Jun 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Jun 21 Jun 20 Jun 19 Jun 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 2.36B 2.36B 2.36B 2.36B 2.36B 2.36B
Cash burn (monthly) 268.33M 95.25M 45.67M 44.42M 139.67M (no burn)
Cash used (since last report) 1.16B 410.36M 196.75M 191.36M 601.72M n/a
Cash remaining 1.2B 1.95B 2.16B 2.16B 1.75B n/a
Runway (months of cash) 4.5 20.4 47.3 48.7 12.6 n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Recent insider trades

CAH insider ownership history Insider history
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
14 Jul 22 Scarborough Dean A Phantom Stock Common Shares Grant Acquire A No No 54.05 531 28.7K 6,280
28 Jun 22 Kaufmann Michael C Common Shares Payment of exercise Dispose F No No 54.86 9,523 522.43K 540,131
15 May 22 Jason M. Hollar Common Shares Payment of exercise Dispose F No No 55.61 3,392 188.63K 52,125
14 Apr 22 Scarborough Dean A Phantom Stock Common Shares Grant Acquire A No No 62.96 456 28.71K 5,736
15 Mar 22 Mayer Jessica L Common Shares Payment of exercise Dispose F No No 52.61 1,332 70.08K 104,811
Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Institutional ownership, Q1 2022

CAH institutional ownership history Ownership history
13F holders Current Prev Q Change
Total holders 762 762 –
Opened positions 91 123 -26.0%
Closed positions 91 87 +4.6%
Increased positions 276 274 +0.7%
Reduced positions 264 264 –
13F shares Current Prev Q Change
Total value 13.08B 12.01B +8.9%
Total shares 232.07M 233.2M -0.5%
Total puts 2.26M 2.63M -13.9%
Total calls 2.94M 3.85M -23.7%
Total put/call ratio 0.8 0.7 +12.9%
Largest owners Shares Value Change
Vanguard 33.74M $1.91B -5.9%
BLK Blackrock 23.11M $1.31B +5.0%
STT State Street 21.8M $1.25B +2.1%
TROW T. Rowe Price 14.9M $844.77M -0.9%
IVZ Invesco 6.19M $350.75M +9.0%
FMR 5.96M $337.86M +9.5%
BK Bank Of New York Mellon 5.44M $308.38M -1.6%
Geode Capital Management 5.42M $306.72M +2.0%
American Century Companies 4.7M $266.47M -19.0%
NTRS Northern Trust 3.67M $207.92M -0.5%
Largest transactions Shares Bought/sold Change
Norges Bank 0 -2.98M EXIT
Vanguard 33.74M -2.11M -5.9%
Nuveen Asset Management 2.89M +2.1M +264.3%
Two Sigma Investments 536.22K -1.78M -76.8%
CFS Investment Advisory Services 1.51M +1.49M +6455.0%
D. E. Shaw & Co. 549.39K -1.39M -71.7%
Equity Investment 1.12M +1.12M NEW
BLK Blackrock 23.11M +1.11M +5.0%
American Century Companies 4.7M -1.1M -19.0%
JPM JPMorgan Chase & Co. 2.26M +1.03M +84.2%
Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Financial report summary

?
Competition
Owens & Minor • Merit Medical Systems • Alpha Pro Tech • Actavis • Omnicell • Mckesson • Impax Laboratories • Allscripts Healthcare Solutions • Amerisource Bergen • Vycor Medical

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: AmerisourceBergen, capacity, chosen, clothing, Columbia, contracting, daily, eligible, enforcement, evolving, face, fee, height, heightened, infection, inflation, join, joined, maximum, Oklahoma, passage, population, rebounded, recommend, space, stabilized, treaty, unique, unusable, valuation, wearer, week
Removed: exceeded, framework, improve, inquiry, leadership, proposed, reaching, satisfied
From filing 10-Q 2022 Q3
Financial reports
View all
10-Q
2022 Q3
Quarterly report
4 May 22
10-Q
2022 Q2
Quarterly report
3 Feb 22
10-Q
2022 Q1
Quarterly report
9 Nov 21
10-K
2021 FY
Annual report
16 Aug 21
10-Q
2021 Q3
Quarterly report
6 May 21
10-Q
2021 Q2
Quarterly report
5 Feb 21
10-Q
2021 Q1
Quarterly report
5 Nov 20
10-K
2020 FY
Annual report
13 Aug 20
10-Q
2020 Q3
Quarterly report
11 May 20
10-Q
2020 Q2
Quarterly report
6 Feb 20
Current reports
View all
8-K
Other Events
22 Jul 22
8-K
Cardinal Health Reports Third Quarter Fiscal 2022 Results
5 May 22
8-K
Entry into a Material Definitive Agreement
25 Feb 22
8-K
Cardinal Health Reports Second Quarter Fiscal 2022 Results
3 Feb 22
8-K
Cardinal Health Provides Medical Segment Fiscal Year 2022 Financial Update
10 Jan 22
8-K
Departure of Directors or Certain Officers
9 Nov 21
8-K
Cardinal Health Reports First Quarter Fiscal 2022 Results
9 Nov 21
8-K
Cardinal Health reports fourth quarter and full year results for fiscal year 2021
5 Aug 21
8-K
Distributors Announce Proposed Opioid Settlement Agreement
22 Jul 21
8-K
Cardinal Health reports third-quarter results for fiscal year 2021
6 May 21
Registration and prospectus
View all
S-8
Registration of securities for employees
9 Nov 21
S-8
Registration of securities for employees
20 Aug 19
S-3ASR
Automatic shelf registration
20 Aug 19
S-8 POS
Registration of securities for employees (post-effective amendment)
10 Aug 17
S-8 POS
Registration of securities for employees (post-effective amendment)
10 Aug 17
S-8 POS
Registration of securities for employees (post-effective amendment)
10 Aug 17
S-8
Registration of securities for employees
9 Aug 17
424B2
Prospectus for primary offering
4 Jun 17
FWP
Free writing prospectus
1 Jun 17
424B2
Prospectus for primary offering
31 May 17
Proxies
View all
DEFA14A
Additional proxy soliciting materials
25 Oct 21
DEFA14A
Additional proxy soliciting materials
23 Sep 21
DEF 14A
Definitive proxy
23 Sep 21
PRE 14A
Preliminary proxy
10 Sep 21
PX14A6G
Letter to shareholders
23 Oct 20
PX14A6G
Letter to shareholders
19 Oct 20
DEFA14A
Additional proxy soliciting materials
23 Sep 20
DEF 14A
Definitive proxy
23 Sep 20
PRE 14A
Preliminary proxy
8 Sep 20
PX14A6G
Letter to shareholders
4 Nov 19
Other
View all
SD
Conflict minerals disclosure
27 May 22
SD
Conflict minerals disclosure
27 May 21
SD
Conflict minerals disclosure
29 May 20
SD
Conflict minerals disclosure
30 May 19
SD
Conflict minerals disclosure
30 May 18
NO ACT
No action letter
7 Sep 17
NO ACT
No action letter
3 Aug 17
NO ACT
No action letter
2 Aug 17
SD
Conflict minerals disclosure
30 May 17
NO ACT
No action letter
19 Jul 16
Ownership
View all
4
CARDINAL HEALTH / DEAN A SCARBOROUGH ownership change
18 Jul 22
4
CARDINAL HEALTH / Michael C Kaufmann ownership change
30 Jun 22
11-K
Annual report of employee stock purchases
24 Jun 22
11-K
Annual report of employee stock purchases
24 Jun 22
4
CARDINAL HEALTH / Jason M. Hollar ownership change
17 May 22
4
CARDINAL HEALTH / DEAN A SCARBOROUGH ownership change
18 Apr 22
4
CARDINAL HEALTH / Jessica L Mayer ownership change
16 Mar 22
4
CARDINAL HEALTH / Brian S Rice ownership change
16 Feb 22
SC 13G
CARDINAL HEALTH / PRICE T ROWE ASSOCIATES ownership change
14 Feb 22
SC 13G/A
CARDINAL HEALTH / STATE STREET ownership change
10 Feb 22

Patents

View all
Utility
Equipment clip for urology and methods for use
9 Aug 22
The present disclosure provides a device for holding at least one conduit.
Utility
Intraluminal device with improved flexibility and durability
2 Aug 22
In accordance with the present invention, there is provided a stent for insertion into a vessel of a patient.
Utility
Rotary debulking atherectomy device with a crossing balloon
26 Jul 22
An atherectomy system that utilizes an anchoring balloon with a rotary debulker and a crossing balloon to remove or debulk lesions formed on the interior wall surface of a body vessel.
Utility
Rapid Exchange Dilator for Sheathless Catheterization
14 Jul 22
A dilator for sheathless access to a vessel of a patient having a tubular distal member with a skived portion on the proximal end and a proximal member with a skived portion on the distal end.
Utility
Patient Positioning System
16 Jun 22
A system and method are disclosed for positioning a patient on an operating table.

Transcripts

View all
2022 Q3
Earnings call transcript
5 May 22
2022 Q2
Earnings call transcript
3 Feb 22
2022 Q1
Earnings call transcript
9 Nov 21
2021 Q4
Earnings call transcript
5 Aug 21
2021 Q3
Earnings call transcript
6 May 21
2021 Q2
Earnings call transcript
5 Feb 21
2020 Q3
Earnings call transcript
5 Nov 20
2020 Q4
Earnings call transcript
6 Aug 20
2020 Q3
Earnings call transcript
11 May 20
2020 Q2
Earnings call transcript
6 Feb 20

Reddit threads

View all